Gradalis, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Carrollton TX United States (2003)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2009
NCT01061840
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Gradalis, Inc.